Holen Sie sich die Stockscreener-App
8.46
6.82%
0.54
Vorhandelsmarkt:
8.56
0.10
+1.18%
Schlusskurs vom Vortag:
$7.92
Offen:
$7.94
24-Stunden-Volumen:
802.99K
Relative Volume:
0.74
Marktkapitalisierung:
$736.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-106.81M
KGV:
-2.5546
EPS:
-3.3117
Netto-Cashflow:
$-8.40M
1W Leistung:
+5.75%
1M Leistung:
+3.30%
6M Leistung:
-13.85%
1J Leistung:
-41.33%
1-Tages-Spanne:
$7.85
$8.53
1-Wochen-Bereich:
$7.735
$8.61
52-Wochen-Spanne:
$5.1501
$16.81
Immunome Inc Stock (IMNM) Company Profile
Firmenname
Immunome Inc
Sektor
Branche
Telefon
610-321-3700
Adresse
18702 N. CREEK PARKWAY, BOTHELL
Vergleichen Sie IMNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
8.46 | 696.10M | 0 | -106.81M | -8.40M | -3.3117 |
|
ONC
Beigene Ltd Adr
|
238.76 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.03 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.85 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.69 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | Lake Street | Buy |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-30 | Eingeleitet | JP Morgan | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-01-29 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-19 | Eingeleitet | Wedbush | Outperform |
| 2021-10-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Immunome Inc Aktie (IMNM) Neueste Nachrichten
Immunome to Present at Upcoming Investor Conferences - BioSpace
Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Northern Trust Corp - Defense World
Immunome, Inc. Reports Q1 2025 Financial Results - TipRanks
Immunome stock rating cut to Hold by Boral Capital - Investing.com Nigeria
Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates - MSN
Leerink Partnrs Has Strong Estimate for Immunome Q2 Earnings - Defense World
Voya Investment Management LLC Has $166,000 Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
All You Need to Know About Immunome (IMNM) Rating Upgrade to Buy - MSN
Immunome (NASDAQ:IMNM) Shares Gap Up Following Earnings Beat - Defense World
Immunome (IMNM) Financial Update and Clinical Progress in Q1 202 - GuruFocus
Wedbush Adjusts Price Target on Immunome to $21 From $33, Maintains Outperform Rating - marketscreener.com
(IMNM) Investment Report - news.stocktradersdaily.com
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace
Immunome Inc (IMNM) Q1 2025 Earnings: EPS Loss of $0.52 Beats Es - GuruFocus
Immunome Q1 Income From Operations USD -44.636 Million - marketscreener.com
Immunome Expands Share Reserve in Inducement Plan - TipRanks
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update | IMNM Stock News - GuruFocus
Raymond James Financial Inc. Makes New $274,000 Investment in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Wall Street Analysts Believe Immunome (IMNM) Could Rally 249.93%: Here's is How to Trade - MSN
Immunome (IMNM) Expected to Announce Earnings on Tuesday - Defense World
MetLife Investment Management LLC Purchases 5,354 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome, Inc. (NASDAQ:IMNM) Shares Purchased by Wells Fargo & Company MN - Defense World
Invesco Ltd. Cuts Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 2, 2025 - BioSpace
Brokerages Set Immunome, Inc. (NASDAQ:IMNM) Price Target at $25.33 - Defense World
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 563 - GuruFocus
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IMNM Stock News - GuruFocus
(IMNM) Investment Analysis and Advice - news.stocktradersdaily.com
Taking on analysts’ expectations and winning: Immunome Inc (IMNM) - Sete News
Immunome Inc [IMNM] stock for 60,684 USD was acquired by BIENAIME JEAN JACQUES - knoxdaily.com
Legal & General Group Plc Sells 8,796 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome (IMNM) Trades at Significant Discount, Piper Sandler An - GuruFocus
Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’ - TipRanks
Was there any good news for Immunome Inc (IMNM) stock in the last session? - uspostnews.com
Investing in Immunome Inc (IMNM): What You Must Know - knoxdaily.com
A company insider recently bought 7,800 shares of Immunome Inc [IMNM]. Should You Buy? - knoxdaily.com
Financial Snapshot: Analyzing Immunome Inc (IMNM)’s Key Ratio Metrics - DWinneX
Immunome Inc (IMNM)’s stock price in review: A technical analysis - uspostnews.com
Geode Capital Management LLC Has $13.05 Million Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome: Transformed Pipeline Offers Multiple Catalysts (NASDAQ:IMNM) - Seeking Alpha
JPMorgan Chase & Co. Acquires 624,045 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Finanzdaten der Immunome Inc-Aktie (IMNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
6.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):